Market News AIOpen the app

LTRN stock news · Lantern Pharma

Stories about Lantern Pharma (LTRN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for LTRN

Follow Lantern Pharma (LTRN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LTRN
Free on the App Store and Google Play, or on the web.
  1. Nov 21, 2026, 9:11 AM ET · Market

    Lantern Pharma shared updates for Q3 2026, showing progress in its cancer treatment projects using AI.

    Neutral

    Lantern Pharma reported continued work on its cancer-drug research, with no financial results or measured surprises. The update does not change its outlook.

  2. Oct 1, 2026, 4:04 PM ET · Trouble

    Lantern Pharma Inc. has been told it might be removed from Nasdaq for not meeting listing rules.

    Bad for LTRN

    Lantern Pharma failed Nasdaq listing tests after its listed securities stayed below a required value. It has 180 days to fix the problem or risk removal.

  3. Sep 29, 2026, 5:22 PM ET · Market

    12 health care stocks changed a lot in prices after the market closed on Tuesday.

    Neutral

    The article reports Lantern Pharma shares fell 7%, but gives no company news behind the move. It does not change the business outlook.

  4. Sep 23, 2026, 7:52 AM ET · Market

    Lantern Pharma Inc. says it will hold a live webinar about its AI drug development on September 23, 2026.

    Neutral

    Lantern filed a notice about a webinar on its Open-Medicine AI platform; the filing reported no financial or operational results, so the reading of LTRN is unchanged.